Advertisement
Ear/Nose/Throat
Subscribe to Ear/Nose/Throat
View Sample

FREE Email Newsletter

ENTrigue Surgical Announces Sinus Surgery Collaboration with fiagon GmbH

September 6, 2012 2:03 pm | by PRNewswire | News | Comments

ENTrigue Surgical, Inc., a San Antonio, Texas-based company that designs, develops, manufactures and distributes medical devices used for Ear, Nose and Throat surgical procedures, announced today a collaboration agreement with fiagon GmbH, a company based in Berlin, Germany, that develops and manufactures a new generation of intelligent and highly portable navigation systems for ENT...

Cochlear Americas Receives FDA Approval of the World's Thinnest, Full Length Electrode for Cochlear Implantation

June 12, 2012 10:19 am | News | Comments

Cochlear Americas announced today that the US Food & Drug Administration (FDA) has approved the Nucleus CI422 with Slim Straight Electrode, the newest electrode in its broad portfolio of implantable hearing solutions. The Slim Straight, along with other Cochlear electrodes...

Advanced Brain Monitoring Announces Launch of Apnea Guard

May 3, 2012 6:24 am | News | Comments

Advanced Brain Monitoring, Inc. announced the world-wide launch of an important new product in the treatment of sleep apnea, the Apnea Guard®. Apnea Guard is the first validated temporary oral appliance with clinical equivalence to custom oral appliances...

Advertisement

Entellus Medical One-Year Study Results Reaffirm XprESS Multi-Sinus Dilation Tool Safe and Effective in Treatment of Chronic Sinusitis

April 20, 2012 5:44 am | News | Comments

One-year results presented by Dr. David Brodner today during the annual Combined Otolaryngology Spring Meeting in San Diego demonstrate that the Entellus Medicalâ„¢ XprESSâ„¢ Multi-Sinus Dilation Tool may be used safely and with sustained effectiveness to treat...

Oticon, Inc. Introduces Invisible Hearing Device For People Who Want the Ultimate in Discretion

March 30, 2012 6:52 am | News | Comments

SOMERSET, N.J.--(BUSINESS WIRE)--Oticon, Inc. today introduced a tiny new hearing instrument that may make it easier for people with a strong preference for an “invisible” hearing solution to take the first step toward better hearing. On the opening day of the American Academy of Audiology AudiologyNOW!...

Siemens Aims to Improve Hearing Aid Acceptance with XCEL — the New Generation of BestSound Technology

March 30, 2012 6:49 am | News | Comments

BOSTON--(BUSINESS WIRE)--Siemens Hearing Instruments, Inc. today announced XCEL - the new generation of its clinically proven* BestSoundâ„¢ Technology. XCEL accelerates hearing aid acceptance by optimally balancing speech intelligibility and sound quality for each individual hearing...

Lantos Technologies Launches World's First 3D Direct Ear Scanner

March 30, 2012 6:45 am | News | Comments

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Lantos Technologies today announced the launch of its 3D digital scanner for fast and painless measurement of the ear canal. The small, hand-held portable scanner using Lantos' patented dual-wavelength algorithm technology is the first platform...

Torax Medical's LINX Reflux Management System Receives Unanimous Recommendation From FDA Advisory Panel

January 16, 2012 5:13 am | News | Comments

SHOREVIEW, Minn.--(BUSINESS WIRE)--The LINX® Reflux Management System, a novel device for the treatment of Gastroesophageal Reflux Disease (GERD), has received a positive recommendation from the Food and Drug Administration's (FDA) Gastroenterology and Urology Devices Advisory Panel.

Advertisement

Waterproof Neptune Sound Processor from Advanced Bionics Receives TÃœV Approval

January 9, 2012 5:50 am | News | Comments

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in Europe for Neptuneâ„¢, the world's first and only swimmable, waterproof sound processor. On December 1, AB announced FDA approval...

Nanofiber Solutions Develops World's First Synthetic Tracheal Implant Made from Nanofibers to be Successfully Transplanted into Cancer Patient

December 2, 2011 4:16 am | News | Comments

COLUMBUS, Ohio – Nanofiber Solutions, LLC, announced today the first successful transplant of its electrospun nanofiber tissue engineered tracheal implant into a 30-year old Baltimore resident, Christopher Lyles, who was diagnosed with inoperable tracheal cancer.

Physician Launches MDHearingAid® to Provide Low-Cost Hearing Aids to Americans Who Need to Hear Clearly

November 11, 2011 4:45 am | News | Comments

CHICAGO--(BUSINESS WIRE)--An award-winning physician and professor has launched MDHearingAid®, a company that provides affordable, high-quality hearing aids for people with mild to moderately-severe hearing loss.

Starkey's AMP Wins Consumer Electronics Show Innovations 2012 Award

November 10, 2011 5:17 am | News | Comments

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Laboratories, Inc., one of the world's leading hearing technology companies, is excited to announce that it has been named an International CES Innovations 2012 Design and Engineering Awards Honoree for its AMPâ„¢ hearing aid.

AACR Releases Landmark Cancer Progress Report

September 20, 2011 5:35 am | by AACR | News | Comments

Tweet   Report Calls on Congress to Provide Critical Funding Increases for Life-saving Research Supported by the NIH and NCI WASHINGTON, D.C. — The American Association for Cancer Research will unveil the AACR Cancer Progress Report 2011 at 3:30 p.m. ET on Tuesday, Sept. 20,...

Advertisement

Edison Pharmaceuticals, Inc. Closes Financing

September 13, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Sept. 13, 2011 /- Edison Pharmaceuticals, Inc. announced today that it has closed a Series E Preferred Financing. Capital raised will fund US and European approval trials for the company's clinical candidates, EPI-A0001 and EPI-743. Terms of the financing were not...

ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers

September 8, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 8, 2011 /- ChromaDex® Corp. (OTCBB: CDXC) today announced that the University of California, Irvine has granted ChromaDex® the exclusive rights to a joint patent application filed by ChromaDex® and the university for the method of inducing...

American Animal Hospital Association and Heska Corporation Announce New Online Continuing Education Series

September 6, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

LOVELAND, Colo., Sept. 6, 2011 /- The American Animal Hospital Association (AAHA) and Heska Corporation (NASDAQ: HSKA ) are collaborating on a new series for online continuing education. Using the complexities and challenges of real-life examples, the "Solve It! Series"...

Prostate Cancer Awareness Month Starts in September

September 2, 2011 4:34 am | by Bio-Medicine.Org | News | Comments

CORAL SPRINGS, Fla., Sept. 2, 2011 /- What do Robert DeNiro, Hugo Chavez, Rudy Giuliani, Roger Moore, John Kerry, Don Imus, Harry Belafonte, Nelson Mandela, Colin Powell, Frank Zappa, Telly Savalas, Bill Bixby and Timothy Leary all have in common? If your answer is prostate cancer, then...

Kimberly-Clark Health Care Announces Selling Price Increase

September 1, 2011 12:37 pm | by Bio-Medicine.Org | News | Comments

ROSWELL, Ga., Sept. 1, 2011 /- Kimberly-Clark Health Care (KCHC) announced today that it is implementing a double-digit price increase on synthetic exam gloves due to unprecedented demand for and rising costs of raw materials, particularly butadiene and acrylonitrile.   "Despite...

New Drug Approved for Treatment of Non Small Cell Lung Cancer in Specific Patient Population

September 1, 2011 12:36 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 1, 2011 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive.  The drug was approved based on data from two clinical...

MIT cites new approaches with microRNA testing

August 31, 2011 11:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Researchers at MIT say they have engineered a new method to detect abnormal microRNA levels in the blood of cancer patients, raising the possibility of developing a simple blood test to diagnose or monitor the disease.

IRIDEX Expands ENT Laser Applications

August 31, 2011 2:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Aug. 31, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) announced the introduction of its new XP Module - a high power factory installed option for the IRIDEX IQ 532 green laser system. The IQ 532 XP is a multifunctional device that can be utilized by both ear, nose...

The Pancreatic Cancer Action Network and AACR to Award More Than $3.1 Million in Pancreatic Cancer Research Grants

August 29, 2011 5:35 am | by AACR | News | Comments

Tweet Pancreatic Cancer Action Network-AACR Grants will Open for Applications on Sept. 1, 2011 PHILADELPHIA - The Pancreatic Cancer Action Network and the American Association for Cancer Research are pleased to announce the opening of the 2012 research grants program on Sept. 1, 2011. The...

LUNGevity Foundation Praises Recent FDA Approval of New Lung Cancer Treatment Drug XALKORI® (crizotinib)

August 27, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 27, 2011 /PRNewswire-USNewswire/ -- LUNGevity Foundation applauds the US Food and Drug Administration's (FDA) recent approval of XALKORI® (crizotinib) to treat lung cancer. The drug, introduced by Pfizer, Inc. showed such promise in early trials that it was given...

B.U. to share in $19M breast cancer research grant

August 26, 2011 4:51 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Boston University will share in a $19.3 million grant to study racial disparities in breast cancer diagnosis and treatment.

Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System

August 22, 2011 3:52 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 22, 2011 /- Delcath Systems, Inc. (NASDAQ: DCTH ) reported encouraging top-line results from the hepatobiliary cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer. This study,...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading